Department of Internal Medicine II, Kliniken des Landkreises Neumarkt i.d.OPf, Nürnberger Str. 12, 92318, Neumarkt in der Oberpfalz, Germany.
Department of Medicine II, Malteser Waldkrankenhaus St. Marien Erlangen, Erlangen, Germany.
Tech Coloproctol. 2019 Oct;23(10):957-963. doi: 10.1007/s10151-019-02043-5. Epub 2019 Jul 31.
Endoscopic full-thickness resection (EFTR) significantly expands the spectrum of endoscopic colorectal resection methods for lesions that show no lifting sign, submucosal lesions and mucosal carcinomas. The aim of our study was to evaluate the efficacy and safety of EFTR using a commercially available full thickness resection device (FTRD) by assessing the completeness of the full-thickness resection, the technical success, as well as complications in a cohort of patients from three referral centers in Germany. Another aim was to determine which patient subpopulations benefit most in clinical practice.
This retrospective multicenter study was conducted on consecutive patients who were admitted to three referral centers in Germany between November 2014 and December 2017. The EFTR was conducted according to the standard indications using the FTRD System (OVESCO, Tübingen, Germany). Data were obtained from prospectively maintained institutional databases.
There were 70 patients, 42 males and 25 females with a mean age of 79.5 years (range 25-89 years) who had colonoscopy for EFTR. In three patients EFTR was not feasible because the lesions were too large. Of the remaining 67 patients, 52 had recurrent adenomas, 10 had high-grade intraepithelial neoplasia or mucosal carcinoma and five had a subepithelial lesion. Resection was technically successful in 65 patients (97.0%). Histologically complete resection (R0) was achieved in 59/65 patients (90.8%). The R0 resection rate was lower for lesions > 20 mm (86.5%) versus lesions ≤ 20 mm (92.9%). The total complication rate was 14.9%: there was one major complication (perforation of sigmoid colon), while all other complications were minor.
EFTR yields excellent resection rates for benign recurrent adenomas with non-lifting sign, advanced histopathological findings or submucosal lesions when the procedure is performed in experienced hands and for the correct indication. Thus, surgery can be avoided in many cases. For all lesions the risk of R1 resection goes up with the size of the lesion and careful patient selection is mandatory.
内镜全层切除术(EFTR)显著扩大了内镜结直肠切除术的范围,适用于无提升征、黏膜下病变和黏膜癌的病变。我们的研究目的是通过评估三家德国转诊中心的一组患者的全层切除的完整性、技术成功率以及并发症,来评估使用市售全层切除装置(FTRD)进行 EFTR 的疗效和安全性。另一个目的是确定哪些患者亚群在临床实践中受益最大。
这是一项回顾性多中心研究,纳入了 2014 年 11 月至 2017 年 12 月期间在德国三家转诊中心接受治疗的连续患者。EFTR 是根据标准适应证使用 FTRD 系统(OVESCO,德国图宾根)进行的。数据来自于前瞻性维护的机构数据库。
共有 70 例患者,42 例为男性,25 例为女性,平均年龄 79.5 岁(25-89 岁),因 EFTR 行结肠镜检查。有 3 例患者因病变过大而无法进行 EFTR。在其余 67 例患者中,52 例为复发性腺瘤,10 例为高级别上皮内瘤变或黏膜癌,5 例为黏膜下病变。65 例患者的切除技术成功(97.0%)。59/65 例患者(90.8%)获得了组织学上的完全切除(R0)。20mm 以上病变的 R0 切除率较低(86.5%),20mm 以下病变的 R0 切除率较高(92.9%)。总的并发症发生率为 14.9%:有一例严重并发症(乙状结肠穿孔),其余均为轻微并发症。
EFTR 在经验丰富的医生手中,针对具有非提升征、高级别组织学发现或黏膜下病变的良性复发性腺瘤、进展期病变进行操作时,可获得良好的切除率,避免了手术。对于所有病变,随着病变大小的增加,R1 切除的风险增加,因此需要仔细选择患者。